U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.
Metazocine is a synthetic opioid analgesic with reinforcing properties and PCP-like activity. Metazocine is a Schedule II controlled substance. Metazocine acts as a ligand at opioid, sigma and NMDA receptors. Metazocine enantiomers exert different pharmacological activity.

Originator

Curator's Comment: reference retrieved from https://www.drugfuture.com/chemdata/metazocine.html

Approval Year

PubMed

PubMed

TitleDatePubMed
Patents
Substance Class Mixture
Created
by admin
on Wed Apr 02 10:24:57 GMT 2025
Edited
by admin
on Wed Apr 02 10:24:57 GMT 2025
Record UNII
XD53YGT34W
Record Status FAILED
Record Version
  • Download
Name Type Language
METAZOCINE
INN   MI  
INN  
Official Name English
IDS-NM-001
Preferred Name English
METAZOCINE, (±)-
Common Name English
METAZOCINE [MI]
Common Name English
1,2,3,4,5,6-HEXAHYDRO-3,6,11-TRIMETHYL-2,6-METHANO-3-BENZAZOCIN-8-OL
Common Name English
1,2,3,4,5,6-HEXAHYDRO-8-HYDROXY-3,6,11-TRIMETHYL-2,6-METHANO-3-BENZAZOCINE
Common Name English
2,6-METHANO-3-BENZAZOCIN-8-OL, 1,2,3,4,5,6-HEXAHYDRO-3,6,11-TRIMETHYL-
Systematic Name English
METHOBENZMORPHAN
Common Name English
metazocine [INN]
Common Name English
2'-HYDROXY-2,5,9-TRIMETHYL-6,7-BENZOMORPHAN
Common Name English
Classification Tree Code System Code
DEA NO. 9240
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
NCI_THESAURUS C241
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID90175554
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
PRIMARY
NCI_THESAURUS
C96731
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
PRIMARY
MESH
C047238
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
PRIMARY
ECHA (EC/EINECS)
223-097-3
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
PRIMARY
PUBCHEM
45479834
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
PRIMARY PUBCHEM
EVMPD
SUB08820MIG
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
PRIMARY
INN
942
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
PRIMARY
WIKIPEDIA
METAZOCINE
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
PRIMARY
FDA UNII
XD53YGT34W
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
PRIMARY
MERCK INDEX
m7275
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
PRIMARY Merck Index
CAS
3734-52-9
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
PRIMARY
SMS_ID
100000081220
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
PRIMARY
ChEMBL
CHEMBL257661
Created by admin on Wed Apr 02 10:24:57 GMT 2025 , Edited by admin on Wed Apr 02 10:24:57 GMT 2025
PRIMARY
All of the following components must be present:
Related Record Type Details
SALT/SOLVATE -> PARENT
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
Related Record Type Details
ACTIVE MOIETY
Definition References